Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2024-12-04 00:00:00 ET · period of report 2024-12-02 · accession 0001628280-24-049897 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-04 | 2024-12-02 | VIR | de Verneuil Vanina | EVP, GC | S - Sale | $8.22 | -76 | 57.0K | -0.1% | -$624.72 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-02 | S | D | 76 | $8.22 | 56,973 | D | — | — | (F2) Reflects ownership after acquisition by the reporting person on November 29, 2024 of 76 shares of common stock pursuant to the Issuer's employee stock purchase program, and sale of such shares on December 2, 2024. |